发明公开
- 专利标题： MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF AUTISTIC DISORDERS
- 专利标题（中）： 的mGlu2 / 3拮抗剂自闭症障碍的治疗
-
申请号： EP13782683.0申请日： 2013-10-21
-
公开(公告)号： EP2925292A1公开(公告)日： 2015-10-07
- 发明人: GATTI MCARTHUR, Silvia , SAXE, Michael , WICHMANN, Juergen , WOLTERING, Thomas
- 申请人： F.Hoffmann-La Roche AG
- 申请人地址： Grenzacherstrasse 124 4070 Basel CH
- 专利权人： F.Hoffmann-La Roche AG
- 当前专利权人： F.Hoffmann-La Roche AG
- 当前专利权人地址： Grenzacherstrasse 124 4070 Basel CH
- 代理机构： Müller-Afraz, Simona
- 优先权： EP12189553 20121023
- 国际公布： WO2014064028 20140501
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61K31/00 ; A61K31/444 ; A61K31/519 ; A61P25/00 ; A61P25/28
摘要：
This invention relates to a new medical use for certain chemical compounds and pharmaceutical compositions containing them. The invention relates to compounds which are mGlu2/3 negative allosteric modulators for use in the treatment of Autistic Spectrum Disorder (ASD), in particular, autism. In another aspect, the invention relates to a pharmaceutical composition for use in the treatment of ASD comprising a compound according to the invention and a pharmaceutically acceptable carrier.
信息查询
